Local Cecal Cancer - Optimization of Surgical Treatment
Recruiting
N/A
Interventional Study
Colonic Neoplasms Malignant
Cecal Neoplasms
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 200 (estimated)
- Sponsor
- Moscow Clinical Scientific Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to determine the clinical efficacy, safety, and oncologic outcomes of ileocecal resection (ICR) with D3 lymphadenectomy compared to standard right hemicolectomy(RHC) for cecal cancer.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* At least 18 years of age.
* ECOG status 0-2.
* Histologically confirmed adenocarcinoma of the colon.
* Clinical stage T1-3; N+; M0.
* The physical status from ASA classification I, II, III or IV.
* Written informed consent.
Exclusion Criteria:
* Synchronous or metachronous m…
Contacts